Abstract:
:Tumorigenesis is often associated with an unbalanced protein homeostasis (proteostasis) network, which sensitizes cancer cells to drugs targeting protein quality control (PQC) regulators. In this issue of Cancer Cell, Anderson and colleagues investigated the anti-cancer activity of a new class of inhibitor against a multi-functional ATPase essential for proteostasis maintenance.
journal_name
Cancer Celljournal_title
Cancer cellauthors
Xia D,Ye Ydoi
10.1016/j.ccell.2015.10.006subject
Has Abstractpub_date
2015-11-09 00:00:00pages
550-552issue
5eissn
1535-6108issn
1878-3686pii
S1535-6108(15)00383-9journal_volume
28pub_type
评论,杂志文章相关文献
CANCER CELL文献大全abstract::The molecular mechanisms regulating leukemia-initiating cell (LIC) function are of important clinical significance. We use chronic myelogenous leukemia (CML) as a model of LIC-dependent malignancy and identify the interaction between the ubiquitin ligase Fbw7 and its substrate c-Myc as a regulator of LIC homeostasis. ...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2013.01.025
更新日期:2013-03-18 00:00:00
abstract::When the COVID-19 pandemic began, formal frameworks to collect data about affected patients were lacking. The COVID-19 and Cancer Consortium (CCC19) was formed to collect granular data on patients with cancer and COVID-19 at scale and as rapidly as possible. CCC19 has grown from five initial institutions to 125 instit...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2020.10.022
更新日期:2020-12-14 00:00:00
abstract::Gene alterations play a prominent role in driving cancer initiation and progression. However, the genetic events that occur in normal cells prior to tumorigenesis are still unknown. Recent studies have started to map somatic mutations in normal human tissues, and here we discuss their implications for our understandin...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2020.11.002
更新日期:2020-11-17 00:00:00
abstract::The dynamic and reversible N6-methyladenosine (m6A) RNA modification installed and erased by N6-methyltransferases and demethylases regulates gene expression and cell fate. We show that the m6A demethylase ALKBH5 is highly expressed in glioblastoma stem-like cells (GSCs). Silencing ALKBH5 suppresses the proliferation ...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2017.02.013
更新日期:2017-04-10 00:00:00
abstract::The receptor tyrosine kinase HER2 enhances tumor metastasis; however, its role in homing to metastatic organs is poorly understood. The chemokine receptor CXCR4 has recently been shown to mediate the movement of malignant cancer cells to specific organs. Here, we show that HER2 enhances the expression of CXCR4, which ...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2004.09.027
更新日期:2004-11-01 00:00:00
abstract::Current strategies combining anti-angiogenic drugs with chemotherapy provide clinical benefit in cancer patients. It is assumed that anti-angiogenic drugs, such as bevacizumab, transiently normalize abnormal tumor vasculature and contribute to improved delivery of subsequent chemotherapy. To investigate this concept, ...
journal_title:Cancer cell
pub_type: 临床试验,杂志文章
doi:10.1016/j.ccr.2011.11.023
更新日期:2012-01-17 00:00:00
abstract::Polymorphonuclear neutrophils (PMNs) are largely considered to foster cancer development despite wielding an arsenal of cytotoxic agents. Using a mouse model of PTEN-deficient uterine cancer, we describe a surprising inhibitory role for PMNs in epithelial carcinogenesis. By inducing tumor cell detachment from the base...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2015.11.005
更新日期:2015-12-14 00:00:00
abstract::Defective V(D)J rearrangement of immunoglobulin heavy or light chain (IgH or IgL) or class switch recombination (CSR) can initiate chromosomal translocations. The DNA-damage kinase ATM is required for the suppression of chromosomal translocations but ATM regulation is incompletely understood. Here, we show that mice l...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccr.2011.03.022
更新日期:2011-05-17 00:00:00
abstract::Mdmx is a critical negative regulator of the p53 pathway that is stoichiometrically limiting in some tissues. Posttranslational modification and degradation of Mdmx after DNA damage have been proposed to be essential for p53 activation. We tested this model in vivo, where critical stoichiometric relationships are pres...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2009.05.008
更新日期:2009-07-07 00:00:00
abstract::TERT promoter mutations reactivate telomerase, allowing for indefinite telomere maintenance and enabling cellular immortalization. These mutations specifically recruit the multimeric ETS factor GABP, which can form two functionally independent transcription factor species: a dimer or a tetramer. We show that genetic d...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2018.08.003
更新日期:2018-09-10 00:00:00
abstract::Deregulation of E2F1 activity and resistance to TGFbeta are hallmarks of gastric cancer. MicroRNAs (miRNAs) are small noncoding RNAs frequently misregulated in human malignancies. Here we provide evidence that the miR-106b-25 cluster, upregulated in a subset of human gastric tumors, is activated by E2F1 in parallel wi...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2008.02.013
更新日期:2008-03-01 00:00:00
abstract::Even in the presence of an adequate oxygen supply, many tumors metabolize the majority of the glucose they take up through glycolysis. It has been a long-held belief that this glycolytic phenotype is due to cancer-specific defects in mitochondrial oxidative phosphorylation. In this issue of Cancer Cell, Fantin et al. ...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccr.2006.05.012
更新日期:2006-06-01 00:00:00
abstract::Epigenetic changes are the most common alterations in human cancer, but it has been difficult to sort out cause and effect from studies of human tumors. Several recent nonlethal mouse models implicate both hypomethylation and loss of imprinting (LOI) in tumor formation, including a paper in this issue of Cancer Cell s...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2005.09.014
更新日期:2005-10-01 00:00:00
abstract::Acute promyelocytic leukemia (APL) is caused by chromosomal translocations that involve the retinoic acid receptor alpha (RAR) and several other genes to yield X-RAR fusion proteins. Unlike wild-type RARs, which require heterodimerization with the retinoid X receptor (RXR) for their function as DNA-binding transcripti...
journal_title:Cancer cell
pub_type: 评论,杂志文章,评审
doi:10.1016/j.ccr.2007.06.012
更新日期:2007-07-01 00:00:00
abstract::The genetic mechanisms responsible for increased incidence of lymphoma in immunocompromised individuals have not been fully elucidated. We show that, in a line of TCR transgenic TG-B mice, an insertional mutation in one allele of the Epm2a locus and epigenetic silencing of another led to a high rate of lymphoma with e...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2006.08.008
更新日期:2006-09-01 00:00:00
abstract::The proapoptotic death receptor DR5 has been studied extensively in cancer cells, but its action in the tumor microenvironment is not well defined. Here, we uncover a role for DR5 signaling in tumor endothelial cells (ECs). We detected DR5 expression in ECs within tumors but not normal tissues. Treatment of tumor-bear...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2012.05.014
更新日期:2012-07-10 00:00:00
abstract::Adaptive resistance to PI3K-mTOR inhibitors potentially limits the clinical antitumor activities of these agents. In this issue of Cancer Cell, Britschgi and coworkers show that certain tumors acquire resistance to PI3K-mTOR inhibitors through activation of a JAK2-dependent pathway, leading to interleukin-8 secretion....
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccr.2012.11.012
更新日期:2012-12-11 00:00:00
abstract::The hedgehog (Hh) signaling pathway plays many roles in invertebrate and vertebrate development. For example, specific inhibition of sonic Hh expression is critical during early stages of pancreas organogenesis, but an active Hh pathway appears to be required for maintenance of adult endocrine functions. Mutational in...
journal_title:Cancer cell
pub_type: 杂志文章,评审
doi:10.1016/s1535-6108(03)00246-0
更新日期:2003-10-01 00:00:00
abstract::ARID1A encodes an SWI/SNF chromatin-remodeling factor and is frequently mutated in various cancers. This study demonstrates that ARID1A-deficient cancer cells are specifically vulnerable to inhibition of the antioxidant glutathione (GSH) and the glutamate-cysteine ligase synthetase catalytic subunit (GCLC), a rate-lim...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2018.12.009
更新日期:2019-02-11 00:00:00
abstract::Heterozygous somatic mutations in the spliceosome gene U2AF1 occur in ∼ 11% of patients with myelodysplastic syndromes (MDS), the most common adult myeloid malignancy. It is unclear how these mutations contribute to disease. We examined in vivo hematopoietic consequences of the most common U2AF1 mutation using a doxyc...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2015.04.008
更新日期:2015-05-11 00:00:00
abstract::Neuroblastoma is an embryonal tumor of the sympathetic nervous system and the most common extracranial tumor of childhood. By sequencing transcriptomes of low- and high-risk neuroblastomas, we detected differentially expressed annotated and nonannotated long noncoding RNAs (lncRNAs). We identified a lncRNA neuroblasto...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2014.09.014
更新日期:2014-11-10 00:00:00
abstract::The childhood brain tumor, medulloblastoma, includes four subtypes with very different prognoses. Here, we show that paracrine signals driven by mutant β-catenin in WNT-medulloblastoma, an essentially curable form of the disease, induce an aberrant fenestrated vasculature that permits the accumulation of high levels o...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2016.03.002
更新日期:2016-04-11 00:00:00
abstract::Mutant RAS-driven tumorigenesis was thought for decades to arise independently of wild-type RAS isoforms, but recent evidence indicates wild-type isoforms are involved. In this issue of Cancer Cell, Grabocka and colleagues report how the loss of wild-type RAS alters oncogenic signaling and dampens the DNA-damage respo...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccr.2014.01.029
更新日期:2014-02-10 00:00:00
abstract::In this issue of Cancer Cell, Sonoshita et al. report that Aes/Grg5 prevents metastasis of colorectal cancer cells by sequestering and inactivating Notch transcriptional effectors in distinct nuclear foci. Loss of Aes/Grg5 in invasive cancer cells where Notch is activated by stroma-expressed ligands promotes invasion,...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccr.2011.01.003
更新日期:2011-01-18 00:00:00
abstract::BCL-2 proteins are critical for cell survival and are overexpressed in many tumors. ABT-737 is a small-molecule BH3 mimetic that exhibits single-agent activity against lymphoma and small-cell lung cancer in preclinical studies. We here report that ABT-737 effectively kills acute myeloid leukemia blast, progenitor, and...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2006.10.006
更新日期:2006-11-01 00:00:00
abstract::Whether metastasis-specific genetic alterations exist remains controversial. The study by Yates et al. in this issue of Cancer Cell provides evidence that metastases emerge late during primary breast cancer progression and that additional driver mutations are often acquired, posing both challenges and opportunities fo...
journal_title:Cancer cell
pub_type: 评论,杂志文章
doi:10.1016/j.ccell.2017.07.011
更新日期:2017-08-14 00:00:00
abstract::Immunotherapy has changed the landscape of cancer treatment. Checkpoint blockade therapies unleash breaks in the immune system and induce long-lasting responses. However, a significant number of patients do not respond (innate resistance), and a subset progress after responding (acquired resistance). A better understa...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2017.05.010
更新日期:2017-06-12 00:00:00
abstract::Inhibition of ERK-MAPK signaling by expression of dominant-negative MEK1 in the tumor vasculature suppresses angiogenesis and tumor growth. In an organotypic tissue culture angiogenesis assay, ERK-MAPK inhibition during the migratory phase results in loss of bipolarity, detachment, and cell death of isolated endotheli...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccr.2005.12.021
更新日期:2006-01-01 00:00:00
abstract::MYC is an oncogenic driver that regulates transcriptional activation and repression. Surprisingly, mechanisms by which MYC promotes malignant transformation remain unclear. We demonstrate that MYC interacts with the G9a H3K9-methyltransferase complex to control transcriptional repression. Inhibiting G9a hinders MYC ch...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2018.09.001
更新日期:2018-10-08 00:00:00
abstract::Neuro-glial activation is a recently identified hallmark of growing cancers. Targeting tumor hyperinnervation in preclinical and small clinical trials has yielded promising antitumor effects, highlighting the need of systematic analysis of neural influences in cancer (NIC). Here, we outline the strategies translating ...
journal_title:Cancer cell
pub_type: 杂志文章
doi:10.1016/j.ccell.2020.05.023
更新日期:2020-07-13 00:00:00